Bill

Bill > S1558


MA S1558

To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing


summary

Introduced
01/23/2017
In Committee
01/23/2017
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

190th General Court

Bill Summary

For legislation to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing. Revenue.

AI Summary

This bill aims to eliminate the tax deduction for pharmaceutical companies' direct-to-consumer advertising of prescription drugs and devices in Massachusetts. Specifically, it would disallow the deduction for all direct and indirect costs related to advertising prescription drugs and devices to patients, including media advertising, coupons, outreach and persistency programs, and other forms of marketing directed at individuals rather than licensed prescribers. For national or regional programs, the disallowed amount would be the proportionate share of expenses directed to Massachusetts residents.

Committee Categories

Budget and Finance

Sponsors (4)

Last Action

Accompanied a study order, see S2497 (on 04/30/2018)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...